Screener
Health Catalyst HCAT Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$70.5MBeat by $1.4M
EPS$0.04Beat by $0.01
Revenue estimate$69.1M
EPS estimate$0.03
“We delivered a very productive second quarter, exceeding the high end of our revenue guidance and the midpoint of our adjusted EBITDA guidance. More importantly, we recently closed the Vitalware divestiture and fully repaid our credit facility debt, which significantly improves our balance sheet and provides flexibility to make measured near-term bets in the work we believe in most. After eighteen years working with health systems, we know how to drive outcomes. We believe our intelligence products can help them improve outcomes faster. That's the company we're working to build.”
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$55.4M
EPS estimate-$0.02
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Health Catalyst report Q2 2026 earnings?
- Health Catalyst (HCAT) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Health Catalyst's Q2 2026 revenue and EPS?
- Health Catalyst reported revenue of $70.5M and eps of $0.04 for Q2 2026.
- Did Health Catalyst beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $69.1M by $1.4M. EPS beat the consensus estimate of $0.03 by $0.01.
- How did Health Catalyst's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 12.7% from $80.7M a year earlier and eps grew 0.0% from $0.04.
- Where can I find Health Catalyst's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001636422-26-000091) and the 10-Q periodic report (0001636422-26-000097) directly on SEC EDGAR. The filing index links above go to sec.gov.
